NOVORIG Trademark

Trademark Overview

On Thursday, August 13, 2020, a trademark application was filed for NOVORIG with the United States Patent and Trademark Office. The USPTO has given the NOVORIG trademark a serial number of 90977298. The federal status of this trademark filing is REGISTERED as of Tuesday, October 4, 2022. This trademark is owned by Rapid Novor Inc.. The NOVORIG trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of new technology for others in the field of biotechnology; Proteomics analysis services for scientific research purposes; Antibody profiling for scientific research purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals; Medical research and medical research analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical laboratory services
novorig

General Information

Serial Number90977298
Word MarkNOVORIG
Filing DateThursday, August 13, 2020
Status700 - REGISTERED
Status DateTuesday, October 4, 2022
Registration Number6863141
Registration DateTuesday, October 4, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2022

Trademark Statements

Goods and ServicesDevelopment of new technology for others in the field of biotechnology; Proteomics analysis services for scientific research purposes; Antibody profiling for scientific research purposes; Laboratory research in the field of immune sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immune sequencing; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals; Medical research and medical research analysis in the field of medicine; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Medical laboratory services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateNOT AVAILABLE
Primary Code042
First Use Anywhere DateThursday, May 28, 2020
First Use In Commerce DateThursday, May 28, 2020

Trademark Owner History

Party NameRapid Novor Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKitchener, Ontario N2G4X8
CA
Party NameRapid Novor Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKitchener, Ontario N2G4X8
CA
Party NameRapid Novor Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKitchener, Ontario N2G4X8
CA

Trademark Events

Event DateEvent Description
Tuesday, October 4, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 4, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 19, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 29, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 16, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 15, 2022ASSIGNED TO LIE
Monday, June 13, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, June 2, 2022NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Wednesday, June 1, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, June 1, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, June 1, 2022SUSPENSION LETTER WRITTEN
Wednesday, June 1, 2022USE AMENDMENT ACCEPTED
Tuesday, May 3, 2022AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, May 3, 2022USE AMENDMENT FILED
Tuesday, May 31, 2022DIVISIONAL PROCESSING COMPLETE
Tuesday, May 3, 2022DIVISIONAL REQUEST RECEIVED
Tuesday, May 31, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 3, 2022TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, May 3, 2022TEAS AMENDMENT OF USE RECEIVED
Tuesday, May 3, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, November 5, 2021NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, November 5, 2021INQUIRY TO SUSPENSION E-MAILED
Friday, November 5, 2021SUSPENSION INQUIRY WRITTEN
Wednesday, May 5, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, May 5, 2021LETTER OF SUSPENSION E-MAILED
Wednesday, May 5, 2021SUSPENSION LETTER WRITTEN
Monday, April 12, 2021ASSIGNED TO EXAMINER
Tuesday, March 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 18, 2021ASSIGNED TO LIE
Wednesday, December 16, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 14, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, December 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 14, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, December 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 14, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 8, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 8, 2020NON-FINAL ACTION E-MAILED
Tuesday, December 8, 2020NON-FINAL ACTION WRITTEN
Tuesday, December 8, 2020ASSIGNED TO EXAMINER
Thursday, September 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

novorig research medical scientific field services fields development immune providing laboratory